Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | -3.72% | -1.56% | +2.04% |
2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.04% | 21.04M | |
+10.38% | 103B | |
+0.91% | 30.28B | |
+10.77% | 21.76B | |
-6.66% | 17.71B | |
+7.02% | 14.26B | |
-5.78% | 12B | |
-4.64% | 10.39B | |
-11.34% | 8.86B | |
-5.68% | 7.97B |
- Stock Market
- Equities
- ALPP Stock
- News Alpine 4 Holdings, Inc.
- Alpine 4 Subsidiary Gets $4.9 Million of New US Government Contracts